Grifols S.A. Logo

Grifols S.A.

Develops and produces plasma-derived medicines and biopharmaceutical solutions.

GRF | MC

Overview

Corporate Details

ISIN(s):
ES0171996087 (+4 more)
LEI:
959800HSSNXWRKBK4N60
Country:
Spain
Address:
Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès

Description

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-11-19 19:02
Grifols informa que el Consejo de Administración no recomendaría a los accionis…
Spanish 39.8 KB
2024-11-19 12:11
En relación con la nota de información privilegiada enviada hoy a la CNMV por B…
Spanish 40.4 KB
2024-11-19 12:02
Brookfield Capital Partners UK Limited comunica información sobre noticias publ…
Spanish 8.6 KB
2024-11-07 17:38
Presentación de Resultados y nota de prensa del tercer trimestre
Spanish 985.9 KB
2024-09-25 18:21
Grifols informa ha recibido de la CNMV la comunicación de que su Comité Ejecuti…
Spanish 90.7 KB
2024-09-23 08:31
El Consejo de Administración de Grifols ha acordado que D. Thomas Glanzmann pas…
Spanish 44.3 KB
2024-07-30 16:21
La CNMV ha decidido levantar la suspensión de Grifols, S.A. con efecto de las 1…
Spanish 156.7 KB
2024-07-30 16:01
Grifols anuncia los resultados financieros del segundo trimestre de 2024
Spanish 680.8 KB
2024-07-19 21:19
Designación de asesores financieros de los consejeros no conflictuados y del Co…
Spanish 106.6 KB
2024-07-16 17:38
Reorganización del Consejo y Comisiones.
Spanish 99.2 KB
2024-07-12 18:36
Otra información relevante.
Spanish 100.6 KB
2024-07-08 11:33
La CNMV ha decidido levantar la suspensión de la negociación de GRIFOLS, S.A. c…
Spanish 147.2 KB
2024-07-04 11:59
Grifols quiere informar que el Sr. Rahul Srinivasan será el nuevo Chief Financi…
Spanish 40.7 KB
2024-07-03 13:28
Grifols informa que los fondos obtenidos con motivo de la transacción de SRAAS …
Spanish 39.5 KB
2024-06-27 18:32
Otra información relevante.
English 107.4 KB

Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Grifols S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Grifols S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.